TuHURA Biosciences, Inc./NV — Form 8-K
Filed November 18, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Form 8-K filed 2026-11-18 reports Item 2.03 (Creation of Direct Financial Obligation or Off-Balance Sheet Arrangement) as of 2026-11-12. The filing document header does not disclose the counterparty, dollar amount, terms, or nature of the obligation — only that such an obligation was created. Full details would require reading the actual 8-K exhibit (hura-20261112.htm), which is not provided in this filing index.
Why this rating
Cannot assess magnitude without disclosed amount. Routine 8-K filing; header alone insufficient to judge materiality relative to $111M market cap.
Extracted items
- 2.03 material obligation
- 9.01 exhibits
See more from November 18, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.